{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:41:00Z","timestamp":1791380460200,"version":"4.3.3"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T00:00:00Z","timestamp":1606089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T00:00:00Z","timestamp":1606089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005040","name":"Bontius Stichting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005040","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00223-020-00780-6","type":"journal-article","created":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T10:42:42Z","timestamp":1606128162000},"page":"346-353","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Increased Prevalence of Malignancies in Fibrous Dysplasia\/McCune-Albright Syndrome (FD\/MAS): Data from a National Referral Center and the Dutch National Pathology Registry (PALGA)"],"prefix":"10.1007","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7787-6997","authenticated-orcid":false,"given":"M.","family":"Hagelstein-Rotman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. E.","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. C. J.","family":"Majoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. H. G.","family":"Cleven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. D. S.","family":"Dijkstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. A. T.","family":"Hamdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A. J.","family":"van de Sande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. M.","family":"Dekkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. M.","family":"Appelman-Dijkstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,23]]},"reference":[{"issue":"12","key":"780_CR1","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1210\/en.2004-0865","volume":"145","author":"LSLJ Weinstein","year":"2004","unstructured":"Weinstein LSLJ, Sakamoto A, Xie T, Chen M (2004) Minireview: GNAS: normal and abnormal functions. Endocrinology 145(12):5459\u20135464","journal-title":"Endocrinology"},{"issue":"6","key":"780_CR2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nrc3521","volume":"13","author":"M O\u2019Hayre","year":"2013","unstructured":"O\u2019Hayre M, Vazquez-Prado J, Kufareva I, Stawiski EW, Handel TM, Seshagiri S, Gutkind JS (2013) The emerging mutational landscape of G-proteins and G-protein coupled receptors in cancer. Nat Rev Cancer 13(6):412\u2013424","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"780_CR3","doi-asserted-by":"crossref","first-page":"E1782","DOI":"10.1210\/jc.2012-1791","volume":"97","author":"AMCW Boyce","year":"2012","unstructured":"Boyce AMCW, Shawker TH, Pinto PA, Linehan WM, Bhattacharryya N, Merino MJ, Singer FR, Collins MT (2012) Characterization and management of testicular pathology in McCune-albright syndrome. J Clin Endocrinol Metab 97(9):E1782\u2013E1790","journal-title":"J Clin Endocrinol Metab"},{"key":"780_CR4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4103\/sni.sni_7_17","volume":"8","author":"DL Penn","year":"2017","unstructured":"Penn DL, Tartarini RJ, Glass CH, De Girolami U, Zamani AA, Dunn IF (2017) Natural history of cranial fibrous dysplasia revealed during long-term follow-up: case report and literature review. Surg Neurol Int 8:209","journal-title":"Surg Neurol Int"},{"issue":"8","key":"780_CR5","first-page":"1848","volume":"87","author":"MREW DiCaprio","year":"2005","unstructured":"DiCaprio MREW (2005) Fibrous dysplasia. Pathophysiology, evaluation and treatment. J Bone Joint Surg Am 87(8):1848\u20131864","journal-title":"J Bone Joint Surg Am"},{"issue":"1","key":"780_CR6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.5858\/arpa.2012.0013-RS","volume":"137","author":"NDBM Riddle","year":"2013","unstructured":"Riddle NDBM (2013) Fibrous dysplasia. Arch Pathol Lab Med 137(1):134\u2013138","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"780_CR7","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2106\/JBJS.18.00062","volume":"101","author":"BCJ Majoor","year":"2019","unstructured":"Majoor BCJ, van de Sande MAJ, Appelman-Dijkstra NM, Leithner A, Jutte PC, Velez R et al (2019) Prevalence and clinical features of mazabraud syndrome: a multicenter European study. J Bone Joint Surg Am 101(2):160\u2013168","journal-title":"J Bone Joint Surg Am"},{"issue":"4","key":"780_CR8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00428-017-2086-2","volume":"470","author":"LD Wood","year":"2017","unstructured":"Wood LD, Noe M, Hackeng W, Brosens LA, Bhaijee F, Debeljak M et al (2017) Patients with McCune-Albright syndrome have a broad spectrum of abnormalities in the gastrointestinal tract and pancreas. Virchows Arch 470(4):391\u2013400","journal-title":"Virchows Arch"},{"issue":"8","key":"780_CR9","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1001\/jamasurg.2014.535","volume":"149","author":"ACJ Parvanescu","year":"2014","unstructured":"Parvanescu ACJ, Ronot M, Hentic O, Grybek V, Couvelard A, Levy P, Chanson P, Ruszniewski P, Sauvanet A, Gaujoux S (2014) Lessons from McCune-albright syndrome-associated intraductal papillary mucinous neoplasms\u2014GNAS-activating mutations in pancreatic carcinogenesis. JAMA Surg 149(8):858\u2013862","journal-title":"JAMA Surg"},{"issue":"1","key":"780_CR10","doi-asserted-by":"crossref","first-page":"E97","DOI":"10.1210\/jc.2013-1823","volume":"99","author":"SSS Gaujoux","year":"2014","unstructured":"Gaujoux SSS, Ronot M, Rangheard AS, Cros J, Belghiti J, Sauvanet A, Ruszniewski P, Chanson P (2014) Hepatobiliary and Pancreatic neoplasms in patients with McCune-Albright syndrome. J Clin Endocrinol Metab 99(1):E97-101","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"780_CR11","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1210\/jc.2002-021642","volume":"88","author":"MTSN Collins","year":"2003","unstructured":"Collins MTSN, Merino MJ, Monroe J, Crawford SE, Krakoff JA, Guthrie LC, Bonat S, Robey PG, Shenker A (2003) Thyroid carcinoma in the McCune-Albright syndrome: contributory role of activating Gs alpha mutations. J Clin Endocrinol Metab 88(9):4413\u20134417","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"780_CR12","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1016\/j.jpag.2015.04.001","volume":"28","author":"NPF Chevalier","year":"2015","unstructured":"Chevalier NPF, Fontana S, Delotte J, Gaspari L, Ferrari P, Sultan C, F\u00e9nichel P (2015) Postpubertal persistent hyperestrogenemia in McCune-albright syndrome: unilateral oophorectomy improved fertility but detected an unexpected borderline epithelial ovarian tumor. J Periatr Adolesc Gynecol 28(6):e169\u2013e172","journal-title":"J Periatr Adolesc Gynecol"},{"issue":"5","key":"780_CR13","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1075-122X.2004.21490.x","volume":"10","author":"TLSR Huston","year":"2004","unstructured":"Huston TLSR (2004) Ductal carcinoma in situ in a 27-year-old woman with McCune-albright syndrome. Breast J 10(5):440\u2013442","journal-title":"Breast J"},{"issue":"1","key":"780_CR14","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jhep.2011.07.018","volume":"56","author":"JC Nault","year":"2012","unstructured":"Nault JC, Fabre M, Couchy G, Pilati C, Jeannot E, Van Nhieu JT, Saint-Paul MC, De Muret A, Redon MJ, Buffet C, Salenave S, Balabaud C, Prevot S, Labrune P, Bioulac-Sage P, Scoazec JY, Chanson P, Zucman-Rossi J (2012) GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation. J Hepatol 56(1):184\u2013191","journal-title":"J Hepatol"},{"issue":"1","key":"780_CR15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/jbmr.3286","volume":"33","author":"BC Majoor","year":"2018","unstructured":"Majoor BC, Boyce AM, Bovee JV, Smit VT, Collins MT, Cleton-Jansen AM et al (2018) Increased risk of breast cancer at a young age in women with fibrous dysplasia. J Bone Miner Res 33(1):84\u201390","journal-title":"J Bone Miner Res"},{"issue":"4","key":"780_CR16","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/path.4153","volume":"229","author":"A Matsubara","year":"2013","unstructured":"Matsubara A, Sekine S, Kushima R, Ogawa R, Taniguchi H, Tsuda H et al (2013) Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum. J Pathol 229(4):579\u2013587","journal-title":"J Pathol"},{"issue":"3","key":"780_CR17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/CMR.0000000000000149","volume":"25","author":"K van den Hurk","year":"2015","unstructured":"van den Hurk K, Balint B, Toomey S, O\u2019Leary PC, Unwin L, Sheahan K et al (2015) High-throughput oncogene mutation profiling shows demographic differences in BRAF mutation rates among melanoma patients. Melanoma Res 25(3):189\u2013199","journal-title":"Melanoma Res"},{"issue":"4","key":"780_CR18","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1158\/1055-9965.EPI-04-0720","volume":"14","author":"UH Frey","year":"2005","unstructured":"Frey UH, Eisenhardt A, Lummen G, Rubben H, Jockel KH, Schmid KW et al (2005) The T393C polymorphism of the G alpha s gene (GNAS1) is a novel prognostic marker in bladder cancer. Cancer Epidemiol Biomarkers Prev 14(4):871\u2013877","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"780_CR19","first-page":"19","volume":"29","author":"M Casparie","year":"2007","unstructured":"Casparie M, Tiebosch AT, Burger G, Blauwgeers H, van de Pol A, van Krieken JH et al (2007) Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol 29(1):19\u201324","journal-title":"Cell Oncol"},{"issue":"12","key":"780_CR20","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1016\/j.humpath.2014.08.016","volume":"45","author":"R Nomura","year":"2014","unstructured":"Nomura R, Saito T, Mitomi H, Hidaka Y, Lee SY, Watanabe S et al (2014) GNAS mutation as an alternative mechanism of activation of the Wnt\/beta-catenin signaling pathway in gastric adenocarcinoma of the fundic gland type. Hum Pathol 45(12):2488\u20132496","journal-title":"Hum Pathol"},{"issue":"3","key":"780_CR21","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/PAS.0000000000000093","volume":"38","author":"A Matsubara","year":"2014","unstructured":"Matsubara A, Sekine S, Ogawa R, Yoshida M, Kasamatsu T, Tsuda H et al (2014) Lobular endocervical glandular hyperplasia is a neoplastic entity with frequent activating GNAS mutations. Am J Surg Pathol 38(3):370\u2013376","journal-title":"Am J Surg Pathol"},{"key":"780_CR22","unstructured":"IKNL. Nederlandse Kankerregistratie. 2017."},{"issue":"2","key":"780_CR23","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/bib\/bbs017","volume":"14","author":"H Thorvaldsdottir","year":"2013","unstructured":"Thorvaldsdottir H, Robinson JT, Mesirov JP (2013) Integrative genomics viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform 14(2):178\u2013192","journal-title":"Brief Bioinform"},{"key":"780_CR24","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s002560050556","volume":"28","author":"R Lopez-Ben","year":"1999","unstructured":"Lopez-Ben R, Pitt MJ, Jaffe KA, Siegal GP (1999) Osteosarcoma in a patient with McCune-Albright syndrome and Mazabraud\u2019s syndrome. Skeletal Radiol 28:522\u2013526","journal-title":"Skeletal Radiol"},{"issue":"3","key":"780_CR25","doi-asserted-by":"crossref","first-page":"e369","DOI":"10.1097\/MD.0000000000000369","volume":"94","author":"N Qu","year":"2015","unstructured":"Qu N, Yao W, Cui X, Zhang H (2015) Malignant transformation in monostotic fibrous dysplasia: clinical features, imaging features, outcomes in 10 patients, and review. Medicine (Baltimore) 94(3):e369","journal-title":"Medicine (Baltimore)"},{"key":"780_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000441-196401000-00001","volume":"247","author":"DTAM Schwartz","year":"1964","unstructured":"Schwartz DTAM (1964) The malignant transformation of fibrous dysplasia. Am J Med Si 247:1\u201320","journal-title":"Am J Med Si"},{"issue":"5","key":"780_CR27","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1002\/1097-0142(19940301)73:5<1411::AID-CNCR2820730516>3.0.CO;2-T","volume":"73","author":"PSF Ruggieri","year":"1994","unstructured":"Ruggieri PSF, Bond JR, Unni KK (1994) Malignancies in fibrous dysplasia. Cancer 73(5):1411\u20131423","journal-title":"Cancer"},{"key":"780_CR28","first-page":"12","volume":"3","author":"CE Dumitrescu","year":"2008","unstructured":"Dumitrescu CE, Collins MT (2008) McCune-Albright syndrome Orphanet. J Rare Dis 3:12","journal-title":"J Rare Dis"},{"issue":"12","key":"780_CR29","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.humpath.2003.08.004","volume":"34","author":"DNEI Jhala","year":"2003","unstructured":"Jhala DNEI, Carroll AJ, Lopez-Ben R, Lopez-Terrada D, Rao PH, Pettenati MJ, Siegal GP (2003) Osteosarcoma in a patient with McCune-Albright syndrome and Mazabraud\u2019s syndrome: a case report emphasizing the cytological and cytogenetic findings. Hum Pathol 34(12):1354\u20131357","journal-title":"Hum Pathol"},{"key":"780_CR30","volume-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism","author":"MT Collins","year":"2013","unstructured":"Collins MT, Bianco P et al (2013) Primer on the metabolic bone diseases and disorders of mineral metabolism. Wiley, Hoboken"},{"issue":"Suppl 1","key":"780_CR31","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1750-1172-7-S1-S4","volume":"7","author":"MT Collins","year":"2012","unstructured":"Collins MT, Singer FR, Eugster E (2012) McCune-Albright syndrome and the extraskeletal manifestations of fibrous dysplasia. Orphanet J Rare Dis. 7(Suppl 1):4","journal-title":"Orphanet J Rare Dis."},{"issue":"9","key":"780_CR32","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s002560050556","volume":"28","author":"RPM Lopez-Ben","year":"1999","unstructured":"Lopez-Ben RPM, Jaffe KA, Siegal GP (1999) Osteosarcoma in a patient with McCune-Albright syndrome and Mazabraud\u2019s syndrome. Skelet Radiol 28(9):522\u2013526","journal-title":"Skelet Radiol"},{"issue":"5\u20136","key":"780_CR33","first-page":"283","volume":"24","author":"FLW Liu","year":"2011","unstructured":"Liu FLW, Yao Y, Li G, Yang Y, Dou W, Zhong D, Wang L, Zhu X, Hu H, Zhang J, Wang R, Chen G (2011) A case of McCune-Albright syndrome associated with pituitary GH adenoma: therapeutic process and autopsy. J Periatr Endocrinol Metab 24(5\u20136):283\u2013287","journal-title":"J Periatr Endocrinol Metab"},{"key":"780_CR34","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3389\/fendo.2019.00268","volume":"10","author":"M Ruchala","year":"2019","unstructured":"Ruchala M, Wolinski K (2019) Health-related complications of acromegaly-risk of malignant neoplasms. Front Endocrinol 10:268","journal-title":"Front Endocrinol"},{"issue":"11","key":"780_CR35","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1002\/cam4.871","volume":"5","author":"T Shanmugalingam","year":"2016","unstructured":"Shanmugalingam T, Bosco C, Ridley AJ, Van Hemelrijck M (2016) Is there a role for IGF-1 in the development of second primary cancers? Cancer Med 5(11):3353\u20133367","journal-title":"Cancer Med"},{"issue":"6","key":"780_CR36","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1158\/1055-9965.EPI-06-1062","volume":"16","author":"NE Allen","year":"2007","unstructured":"Allen NE, Key TJ, Appleby PN, Travis RC, Roddam AW, Rinaldi S et al (2007) Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: results from the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 16(6):1121\u20131127","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"780_CR37","first-page":"2744","volume":"85","author":"P Finne","year":"2000","unstructured":"Finne P, Auvinen A, Koistinen H, Zhang WM, Maattanen L, Rannikko S et al (2000) Insulin-like growth factor I is not a useful marker of prostate cancer in men with elevated levels of prostate-specific antigen. J Clin Endocrinol Metab 85(8):2744\u20132747","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"780_CR38","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/ijc.11544","volume":"108","author":"A Lukanova","year":"2004","unstructured":"Lukanova A, Zeleniuch-Jacquotte A, Lundin E, Micheli A, Arslan AA, Rinaldi S et al (2004) Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer. Int J Cancer 108(2):262\u2013268","journal-title":"Int J Cancer"},{"issue":"Suppl","key":"780_CR39","first-page":"57","volume":"10","author":"K Mikami","year":"2009","unstructured":"Mikami K, Ozasa K, Nakao M, Miki T, Hayashi K, Watanabe Y et al (2009) Prostate cancer risk in relation to insulin-like growth factor (IGF)-I and IGF-binding protein-3: a nested case-control study in large scale cohort study in Japan. Asian Pac J Cancer Prev 10(Suppl):57\u201361","journal-title":"Asian Pac J Cancer Prev"},{"issue":"10","key":"780_CR40","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.ejca.2007.04.014","volume":"43","author":"TM Pham","year":"2007","unstructured":"Pham TM, Fujino Y, Kikuchi S, Tamakoshi A, Yatsuya H, Matsuda S et al (2007) A nested case-control study of stomach cancer and serum insulin-like growth factor (IGF)-1, IGF-2 and IGF-binding protein (IGFBP)-3. Eur J Cancer 43(10):1611\u20131616","journal-title":"Eur J Cancer"},{"issue":"Suppl","key":"780_CR41","first-page":"51","volume":"10","author":"F Sakauchi","year":"2009","unstructured":"Sakauchi F, Nojima M, Mori M, Wakai K, Suzuki S, Tamakoshi A et al (2009) Serum insulin-like growth factors I and II, insulin-like growth factor binding protein-3 and risk of breast cancer in the Japan Collaborative Cohort study. Asian Pac J Cancer Prev 10(Suppl):51\u201355","journal-title":"Asian Pac J Cancer Prev"},{"issue":"11","key":"780_CR42","first-page":"1413","volume":"11","author":"MR Spitz","year":"2002","unstructured":"Spitz MR, Barnett MJ, Goodman GE, Thornquist MD, Wu X, Pollak M (2002) Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-carotene and retinol efficacy trial cohort. Cancer Epidemiol Biomarkers Prev 11(11):1413\u20131418","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"Suppl","key":"780_CR43","first-page":"45","volume":"10","author":"S Suzuki","year":"2009","unstructured":"Suzuki S, Kojima M, Tokudome S, Suzuki K, Ozasa K, Ito Y et al (2009) Insulin-like growth factor (IGF)-I, IGF-II, IGF binding protein-3, and risk of colorectal cancer: a nested case-control study in the Japan collaborative cohort study. Asian Pac J Cancer Prev 10(Suppl):45\u201349","journal-title":"Asian Pac J Cancer Prev"},{"issue":"24","key":"780_CR44","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM199112123252403","volume":"325","author":"LSSA Weinstein","year":"1991","unstructured":"Weinstein LSSA, Gejman PV, Merino MJ, Friedman E, Spiegel AM (1991) Activating mutations of the stimulatory G protein in the McCune\u2013albright syndrome. N Engl J Med 325(24):1688\u20131695","journal-title":"N Engl J Med"},{"issue":"5","key":"780_CR45","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.cancergen.2012.04.001","volume":"205","author":"K Szuhai","year":"2012","unstructured":"Szuhai K, Cleton-Jansen AM, Hogendoorn PC, Bovee JV (2012) Molecular pathology and its diagnostic use in bone tumors. Cancer Genet 205(5):193\u2013204","journal-title":"Cancer Genet"},{"issue":"5","key":"780_CR46","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.tem.2009.02.001","volume":"20","author":"S Fukumoto","year":"2009","unstructured":"Fukumoto S, Martin TJ (2009) Bone as an endocrine organ. Trends Endocrinol Metab 20(5):230\u2013236","journal-title":"Trends Endocrinol Metab"},{"key":"780_CR47","volume-title":"GeneReviews","author":"AM Boyce","year":"1993","unstructured":"Boyce AM, Florenzano P, de Castro LF, Collins MT (1993) Fibrous dysplasia\/McCune-albright syndrome. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K et al (eds) GeneReviews . University of washington, Seattle WA"},{"issue":"3","key":"780_CR48","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cell.2007.05.047","volume":"130","author":"NK Lee","year":"2007","unstructured":"Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C et al (2007) Endocrine regulation of energy metabolism by the skeleton. Cell 130(3):456\u2013469","journal-title":"Cell"},{"issue":"6","key":"780_CR49","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrc.2016.44","volume":"16","author":"PI Croucher","year":"2016","unstructured":"Croucher PI, McDonald MM, Martin TJ (2016) Bone metastasis: the importance of the neighbourhood. Nat Rev Cancer 16(6):373\u2013386","journal-title":"Nat Rev Cancer"},{"issue":"19","key":"780_CR50","doi-asserted-by":"crossref","first-page":"17291","DOI":"10.18632\/oncotarget.4174","volume":"6","author":"S Feng","year":"2015","unstructured":"Feng S, Wang J, Zhang Y, Creighton CJ, Ittmann M (2015) FGF23 promotes prostate cancer progression. Oncotarget 6(19):17291\u201317301","journal-title":"Oncotarget"},{"key":"780_CR51","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ctrv.2017.10.010","volume":"62","author":"AF de Groot","year":"2018","unstructured":"de Groot AF, Appelman-Dijkstra NM, van der Burg SH, Kroep JR (2018) The anti-tumor effect of RANKL inhibition in malignant solid tumors\u2014a systematic review. Cancer Treat Rev 62:18\u201328","journal-title":"Cancer Treat Rev"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-020-00780-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-020-00780-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-020-00780-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,14]],"date-time":"2021-02-14T09:44:56Z","timestamp":1613295896000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-020-00780-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,23]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["780"],"URL":"https:\/\/doi.org\/10.1007\/s00223-020-00780-6","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,23]]},"assertion":[{"value":"11 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Etandards"}},{"value":"M. Hagelstein-Rotman, M.E. Meier, B.C.J. Majoor, A.H.G. Cleven, P.D.S. Dijkstra, N.A.T. Hamdy, M.A.J. van de Sande, O.M. Dekkers, and N.M. Appelman-Dijkstra declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}